Showing results (161-170 of 334) with videos related to
Sort By:
Pageof 34
Antimicrobial Agents and Chemotherapy|November 1, 1988
In vitro activity of E-1040, a novel cephalosporin with potent activity against Pseudomonas aeruginosaH C Neu, N X Chin, A NovelliEuropean Journal of Pharmacology|August 3, 1994
Two components in neurotoxicity by L-2-amino-3-phosphonopropionate in cultured cerebellar neuronsA Novelli, A Torreblanca, M T Fernández-SánchezCanada Diseases Weekly Report = Rapport Hebdomadaire Des Maladies Au Canada|September 1, 1990
Excitatory amino acids toxicity in cerebellar granule cells in primary cultureA Novelli, J Kispert, A Reilly, et al.Antimicrobial Agents and Chemotherapy|July 1, 1989
In vitro activity and beta-lactamase stability of a new carbapenem, SM-7338H C Neu, A Novelli, N X ChinAntimicrobial Agents and Chemotherapy|May 1, 1988
In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolonesN X Chin, A Novelli, H C NeuJournal of Clinical Pharmacy and Therapeutics|January 8, 2009
Increased levels of CA 125 and CA 19.9 serum tumour markers following cyclic combined hormone replacement therapyE Cecchi, F Lapi, A Vannacci, et al.Tumori|June 30, 1982
Estradiol and progestin receptors, 17-beta-hydroxysteroid-dehydrogenase and histopathologic grade in endometrial carcinomaM Ciuffi, L Savino, D Santini, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 17, 2019
Role of novel hormonal therapies in the management of non-metastatic castration-resistant prostate cancer: a literature-based meta-analysis of randomized trialsG Roviello, M R Gatta Michelet, A D'Angelo, et al.Cancer Letters|September 6, 2002
Immunophenotypical markers, ultrastructure and chemosensitivity profile of metastatic melanoma cellsF Prignano, M Coronnello, N Pimpinelli, et al.Journal of Chemotherapy (Florence, Italy)|September 20, 2005
Long-term azithromycin in cystic fibrosis: another possible mechanism of action?U Pradal, A Delmarco, M Morganti, et al.Pageof 34